This topic contains a solution. Click here to go to the answer

Author Question: If the estimates of the coefficients of interest change substantially across specifications, A) ... (Read 241 times)

Engineer

  • Hero Member
  • *****
  • Posts: 527
If the estimates of the coefficients of interest change substantially across specifications,
 
  A) then this can be expected from sample variation.
  B) then you should change the scale of the variables to make the changes appear to be smaller.
  C) then this often provides evidence that the original specification had omitted variable bias.
  D) then choose the specification for which your coefficient of interest is most significant.

Question 2

Applying the analysis from the California test scores to another U.S. state is an example of looking for
 
  A) simultaneous causality bias.
  B) external validity.
  C) sample selection bias.
  D) internal validity.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tanna.moeller

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Answer: C

Answer to Question 2

Answer: B




Engineer

  • Member
  • Posts: 527
Reply 2 on: Jun 29, 2018
YES! Correct, THANKS for helping me on my review


kilada

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

For a complete list of videos, visit our video library